Literature DB >> 26359437

Coagulation factor XIIIa is inactivated by plasmin.

Woosuk S Hur1, Nima Mazinani1, X J David Lu1, Heidi M Britton1, James R Byrnes2, Alisa S Wolberg2, Christian J Kastrup1.   

Abstract

Coagulation factor XIIIa (FXIIIa) is a transglutaminase that covalently cross-links fibrin and other proteins to fibrin to stabilize blood clots and reduce blood loss. A clear mechanism to describe the physiological inactivation of FXIIIa has been elusive. Here, we show that plasmin can cleave FXIIIa in purified systems and in blood. Whereas zymogen FXIII was not readily cleaved by plasmin, FXIIIa was rapidly cleaved and inactivated by plasmin in solution (catalytic efficiency = 8.3 × 10(3) M(-1)s(-1)). The primary cleavage site identified by mass spectrometry was between K468 and Q469. Both plasma- and platelet-derived FXIIIa were susceptible to plasmin-mediated degradation. Inactivation of FXIIIa occurred during clot lysis and was enhanced both in plasma deficient in fibrinogen and in plasma treated with therapeutic levels of tissue plasminogen activator. These results indicate that FXIIIa activity can be modulated by fibrinolytic enzymes, and suggest that changes in fibrinolytic activity may influence cross-linking of blood proteins.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26359437      PMCID: PMC4729541          DOI: 10.1182/blood-2015-07-650713

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  The structure and function of the alpha C domains of fibrinogen.

Authors:  J W Weisel; L Medved
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

2.  Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics.

Authors:  Juri Rappsilber; Yasushi Ishihama; Matthias Mann
Journal:  Anal Chem       Date:  2003-02-01       Impact factor: 6.986

3.  Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.

Authors:  W H Kahr; S Zheng; P M Sheth; M Pai; A Cowie; M Bouchard; T J Podor; G E Rivard; C P Hayward
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

4.  Stable-isotope dimethyl labeling for quantitative proteomics.

Authors:  Jue-Liang Hsu; Sheng-Yu Huang; Nan-Haw Chow; Shu-Hui Chen
Journal:  Anal Chem       Date:  2003-12-15       Impact factor: 6.986

5.  The effect of proteolytic enzymes on fibrin stabilizing factor.

Authors:  M Kopeć; Z S Latallo; M Stahl; Z Wegrzynowicz
Journal:  Biochim Biophys Acta       Date:  1969-07-01

6.  Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

7.  Resistance of factor XIII to degradation or activation by plasmin.

Authors:  D M Rider; J McDonagh
Journal:  Biochim Biophys Acta       Date:  1981-07

8.  Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.

Authors:  K R Siebenlist; D A Meh; M W Mosesson
Journal:  Biochemistry       Date:  1996-08-13       Impact factor: 3.162

9.  Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors.

Authors:  Leonard J Foster; Carmen L De Hoog; Matthias Mann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

10.  Physical determinants of fibrinolysis in single fibrin fibers.

Authors:  Igal Bucay; E Tim O'Brien; Steven D Wulfe; Richard Superfine; Alisa S Wolberg; Michael R Falvo; Nathan E Hudson
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

View more
  16 in total

1.  Coagulation factor XIIIa cross-links amyloid β into dimers and oligomers and to blood proteins.

Authors:  Woosuk S Hur; Nima Mazinani; X J David Lu; Leeor S Yefet; James R Byrnes; Laura Ho; Ju Hun Yeon; Sam Filipenko; Alisa S Wolberg; Wilfred A Jefferies; Christian J Kastrup
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 2.  Newly-Recognized Roles of Factor XIII in Thrombosis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

3.  Activation of factor XIII is accompanied by a change in oligomerization state.

Authors:  Boris A Anokhin; Vilius Stribinskis; William L Dean; Muriel C Maurer
Journal:  FEBS J       Date:  2017-10-03       Impact factor: 5.542

Review 4.  Hemorrhagic blood failure: Oxygen debt, coagulopathy, and endothelial damage.

Authors:  Nathan J White; Kevin R Ward; Shibani Pati; Geir Strandenes; Andrew P Cap
Journal:  J Trauma Acute Care Surg       Date:  2017-06       Impact factor: 3.313

5.  Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients.

Authors:  Marina Marchetti; Patricia Gomez-Rosas; Laura Russo; Sara Gamba; Eleonora Sanga; Cristina Verzeroli; Chiara Ambaglio; Francesca Schieppati; Francesco Restuccia; Ezio Bonanomi; Marco Rizzi; Stefano Fagiuoli; Andrea D'Alessio; Grigorios T Gerotziafas; Luca Lorini; Anna Falanga
Journal:  Front Cardiovasc Med       Date:  2022-06-10

6.  Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Authors:  H M H Spronk; T Padro; J E Siland; J H Prochaska; J Winters; A C van der Wal; J J Posthuma; G Lowe; E d'Alessandro; P Wenzel; D M Coenen; P H Reitsma; W Ruf; R H van Gorp; R R Koenen; T Vajen; N A Alshaikh; A S Wolberg; F L Macrae; N Asquith; J Heemskerk; A Heinzmann; M Moorlag; N Mackman; P van der Meijden; J C M Meijers; M Heestermans; T Renné; S Dólleman; W Chayouâ; R A S Ariëns; C C Baaten; M Nagy; A Kuliopulos; J J Posma; P Harrison; M J Vries; H J G M Crijns; E A M P Dudink; H R Buller; Y M C Henskens; A Själander; S Zwaveling; O Erküner; J W Eikelboom; A Gulpen; F E C M Peeters; J Douxfils; R H Olie; T Baglin; A Leader; U Schotten; B Scaf; H M M van Beusekom; L O Mosnier; L van der Vorm; P Declerck; M Visser; D W J Dippel; V J Strijbis; K Pertiwi; A J Ten Cate-Hoek; H Ten Cate
Journal:  Thromb Haemost       Date:  2018-01-29       Impact factor: 5.249

7.  A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian Woman.

Authors:  Jansen N Seheult; Irina Chibisov
Journal:  Lab Med       Date:  2016-06-10

Review 8.  Biophysical Mechanisms Mediating Fibrin Fiber Lysis.

Authors:  Nathan E Hudson
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

9.  Alterations of the Platelet Proteome in Lung Cancer: Accelerated F13A1 and ER Processing as New Actors in Hypercoagulability.

Authors:  Huriye Ercan; Lisa-Marie Mauracher; Ella Grilz; Lena Hell; Roland Hellinger; Johannes A Schmid; Florian Moik; Cihan Ay; Ingrid Pabinger; Maria Zellner
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

10.  Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective.

Authors:  Sneha Gupta; Arijit Biswas; Mohammad Suhail Akhter; Christoph Krettler; Christoph Reinhart; Johannes Dodt; Andreas Reuter; Helen Philippou; Vytautas Ivaskevicius; Johannes Oldenburg
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.